Results 21 to 30 of about 51,291 (197)
ANTECEDENTES: en 1992 la OMS aprobó el IPSS para evaluar los síntomas del tracto urinario inferior en pacientes de países industrializados; sin embargo, existen poblaciones donde el cuestionario resulta complicado y se obtienen resultados erróneos o ...
D. Estrella
semanticscholar +2 more sources
Background – Polyunsaturated fatty acids (PUFA) can be beneficial in the management of canine atopic dermatitis (cAD). A commercial product PCSO‐524 containing PUFA has demonstrated anti‐inflammatory effects in dogs. Hypothesis/Objectives – To evaluate the efficacy of PCSO‐524, in combination with oclacitinib in dogs with cAD.
Takeo Nishiyama +7 more
wiley +1 more source
Background – A rebound of pruritus occasionally occurs after oclacitinib dose reduction in dogs with atopic dermatitis (AD). Objectives – To determine whether an initial 4‐day course of prednisolone decreases the probability of a pruritus rebound after reducing the frequency of oclacitinib administration.
Thierry Olivry +5 more
wiley +1 more source
Background – Atopic dermatitis (AD) is one of the most common skin diseases in small animal practice. Allergen immunotherapy (AIT) is the only curative treatment for the disease, and oral, subcutaneous and intralymphatic administration of allergens are commonly employed.
Ralf S. Mueller +9 more
wiley +1 more source
Background– Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. Objectives – To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD). Conclusions and clinical relevance – Cannabidiol/CBDA as an adjunct therapy decreased pruritus, and not skin ...
Melissa Loewinger +4 more
wiley +1 more source
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel +4 more
wiley +1 more source
Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability
Aim To evaluate the effect of repeated onabotulinum neurotoxin A injections for the treatment of drooling in children with neurodisabilities. Method This was a retrospective cohort study, in which the first, second, and third onabotulinum neurotoxin A injection were compared within children treated between 2000 and 2020.
Stijn Bekkers +5 more
wiley +1 more source
Background Diagnosis of adverse food reaction (AFR) is based on an eight week elimination diet (ED) and is confirmed by relapse upon re‐challenge with the previously fed diet. Hydrolysed EDs are commonly used for this purpose. Objective To evaluate the commercially available hydrolysed fish protein and rice starch ED Farmina UltraHypo (FUH) for the ...
Chiara Noli, Giorgia Beltrando
wiley +1 more source
One of the most challenging topics in tinnitus clinical studies is the measuring method used. Visual Analogue Scales (VAS) and Tinnitus Handicap Inventory (THI) are frequently used in tinnitus.
R. Figueiredo +2 more
semanticscholar +1 more source
OBJETIVO: Determinar la eficacia de la bupivacaína isobárica subcutánea en herida postquirúrgica de cesárea, como terapia coadyuvante del dolor con AINES mediante la Escala Visual Análoga (EVA).
Karol Yamileth López Godoy
semanticscholar +1 more source

